dual 4-1BB costimulator/anti-FAP (Roche)

N/A

Report date: 2025/03/19 08:56:46

Base Information

Drug Namedual 4-1BB costimulator/anti-FAP (Roche)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsFibroblast activation protein alpha modulators

TargetsProlyl endopeptidase FAPTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRoche Holding Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A